The high expression of DANCR has been linked with tumor progression and poor prognosis in colorectal cancer (Liu et al., 2015), hepatocellular carcinoma (Ma et al., 2016), and gastric cancer (Hao et al., 2017). Here, DANCR is linked to hepatocellular carcinoma.